JBM  Vol.7 No.6 , June 2019
Revisiting the Evaluation of the Effectiveness of Artemether-Lumefantrine Combination in the Treatment of Uncomplicated Malaria in Elele, a Malaria Endemic Area in Rivers State Nigeria
Abstract: Background: The World Health Organization adopted Artenisinin based combination therapy (ACT) for the treatment of uncomplicated malaria in endemic regions. The efficacy of ACT in malaria treatment must have prompted this choice. There’s need to protect the ACT from plasmodial resistance. Hence, clinical scaling up of ACT program is needed. This entails continued assessment, monitoring and evaluation of the effectiveness of component drugs in endemic areas. Purpose: This study revisited the evaluation of the effectiveness of artemether-lumefantrine combination (ALC) in the treatment of uncomplicated malaria in Elele, Nigeria. Method: The study was conducted in Elele, a malaria endemic area in Rivers State, Nigeria. This was a facility based descriptive, cross sectional study at Madonna University Teaching Hospital (MUTH) Elele using simple sampling technique. Qualitative and quantitative data were collected. 100 patients who consented to the study were recruited in the outpatient clinic using semi structured questionnaires as part of study instrument. Inclusion criteria were having a body temperature of ≥37.5&deg;C, symptoms of malaria, positive parasitemia, non ingestion of antimalarial in the past 2 weeks, etc. MUTH ethics committee gave ethical clearance. Patient recruitment following consent commenced with their symptoms and signs recorded at presentation while disappearance of the same was determined following drug ingestion on days 2/4/6/8/10 and 14. The data gotten was analyzed by tallying the responses to get the frequencies using SPSS 16.0 version and Microsoft excel tools. The student t-test was used to calculate the P-value, values < 0.05 was considered statistically significant. Results: Most of the patients knew mosquitoes as the mode of malaria transmission (70%). The ACT is known and used by these patients: artesunate/amodiaquine: 41 (41%); artesunate/lumefantrine: 40 (40%); artesunate/sulphadoxine-pyrimethamine: 38(38%); artesunate/mefloquine: 20 (20%). Fever was the predominant presenting symptom, 92% followed by body weakness (90%); headache (85%); malaise (80%); loss of appetite (80%); nausea (72%); vomiting (70%); abdominal pains (50%). Others were: pallor (30%); hepatomegally (20%); splenomegally (20%); chills (20%); rigor (20%). By day 10 of therapy, fever, vomiting and abdominal pains had disappeared in all patients, some patients still had mild: body weakness 40%; headache 2%; malaise 24%; loss of appetite 20% and nausea 10%. Day 14 recorded no symptoms in all patients. There was effective clinical response (ECR) by day 14. Conclusion: This study hereby reaffirms the efficacy and effectiveness of Artemether-lumefantrine Combination in the treatment of uncomplicated malaria in Elele, Nigeria. The need to fill the existing knowledge gap of monitoring and evaluation of ACT in rural endemic areas has been done by this study.
Cite this paper: Chukwu, L. , Agbasi, P. , Unekwe, P. and Oguwike, F. (2019) Revisiting the Evaluation of the Effectiveness of Artemether-Lumefantrine Combination in the Treatment of Uncomplicated Malaria in Elele, a Malaria Endemic Area in Rivers State Nigeria. Journal of Biosciences and Medicines, 7, 59-72. doi: 10.4236/jbm.2019.76005.

[1]   Federal Republic of Nigeria (2015) National Guideline for Diagnosis and Treatment of Malaria. Third Edition.

[2]   UN Inter-Agency Group for Child Mortality Estimation (2012) Levels and Trends in Child Mortality: Report 2010.

[3]   Byakika-Kibwika, P., et al. (2010) Update on the Efficacy, Effectiveness and Safety of Artemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria. Therapeutics and Clinical Risk Management, 6, 11-20.

[4]   World Health Organization (2001) Antimalarial Drug Combination Therapy: Report of a WHO Technical Consultation. WHO/CDS/RBM/2001.35, WHO, Geneva.

[5]   WHO (2006) Briefing on Malaria Treatment Guidelines and Artemisinin Monotherapies. Geneva.

[6]   Shapiro, T.A. and Goldberg, D.E. (2006) Goldman and Gilman; the Pharmacological Basis of Therapeutics. 11th Edition, McGraw Hill, New York.

[7]   Rosenthal, P.J. (2007) Antiprotozoal Drugs. In: Katzung, B., Ed., Basic and Clinical Pharmacology, 10th Edition, McGraw Hill, New York.

[8]   Rasheed, A., Khan, S.M. and Awan, M.Y. (2011) Efficacy and Safety of Artemehter-Lumefantrine in Uncomplicated Falciparum Malaria in Liberia. Journal of Pakistan Medical Association, 61, 131-134.

[9]   Price, R.N., Nosten, F., Luxemburger, C., ter Kuile, F., Paiphun, L., Chongsuphajaisiddhi, T. and White, N.J. (1996) The Effects of Artemisinin Derivatives on Malaria Transmissability. The Lancet, 347, 1654-1658.

[10]   Nosten, F. and White, N.J. (2007) Artemisinin-Based Combination Treatment of Falciparum Malaria. American Journal of Tropical Medicine and Hygiene, 77, 181-192.

[11]   World Health Organization (2018) International Travel and Health.

[12]   Falade, C.O., Ogunkunle, O.O., Dada-Adegbola, H.O., Falade, A.G., dePalacious, P.I., Hunt, P., et al. (2008) Evaluation of the Efficacy and Safety of Artemether-Lumefantrine in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Nigerian Infants and Children. Malaria Journal, 7, 246.

[13]   Kobbe, R., Klein, P., Adjei, S., Amemasor, S., Thompson, W.N., Heidemann, H., et al. (2008) A Randomized Trial on Effectiveness of Artemether-Lumefantrine versus Artesunate plus Amodiaquine for Unsupervised Treatment of Uncomplicated Plasmodium falciparum Malaria in Ghanian Children. Malaria Journal, 7, 261.

[14]   Mekonnen, S.K., Medhin, G., Berhe, N., Clouse, R.M. and Aseffa, A. (2015) Efficacy of Artemether-Lumefantrine Therapy for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Southwestern Ethiopia. Malaria Journal, 14, 317.

[15]   Map Data @2019 Goggle.

[16]   Singh, R., Musa, J., Singh, S. and Ebere, U.V. (2014) Knowledge, Attitude and Practices on Malaria among the Rural Communities in Aliero, Northern Nigeria. Journal of Family Medicine and Primary Care, 3, 39-41.

[17]   Astatkie, A. (2010) Knowledge and Practice of Malaria Prevention Methods among Residents of Arba Minch Town and Arba Minch Zuria District, Southern Ethiopia. Ethiopian Journal of Health and Medical Sciences of Jimma University, 20, 185-193.

[18]   Wakgari, D., Ahmed, A. and Fikre, E. (2004) Knowledge, Attitude and Practice about Malaria, the Mosquito and Antimalarial Drugs in a Rural Community. Ethiopian Journal of Health Development, 17, 99-104.

[19]   Nsagha, D.S., Njunda, A.L., Kamga, H.L.F., Nsagha, S.M., Assob, J.C.N., et al. (2011) Knowledge and Practices Relating to Malaria in a Semi-Urban Area of Cameroon: Choices and Sources of Antimalarials, Self-Treatment and Resistance. The Pan African Medical Journal, 9, 8.

[20]   Kalilani-Phiri, L.V., Lungu, D. and Coghlan, R. (2011) Knowledge and Malaria Treatment Practices Using Artemisinin Combination Therapy (ACT) in Malawi: Survey of Health Professionals. Malaria Journal, 10, 279.

[21]   Nduka, S.O., Agbata, C.A., Eze, B.H., Ezeobi, I., Nwadukwe, C.C. and Uzodinma, S.U. (2013) Assessment of Artemisinin Based Combination Therapy Utilization among Patent Medicine Vendors in Some Rural Areas in Nigeria. International Journal of Collaborative Research on Internal Medicine and Public Health, 5, 619-629.


[23]   Falade, C.O., Ogundele, A.O., Yusuf, B.O., Ademowo, O.G. and Ladipo, S.M. (2008) High Efficacy of Two Artemisinin Based Combinations (Artemether-Lumefantrine and Artesunate plus Amodiaquine) for Uncomplicated Malaria in Ibadan, Nigeria. Tropical Medicine & International Health, 13, 635-643.

[24]   McGready, R., Tan, S.O., Ashley, E.A., Pimanpanarak, M., Viladpai-Nguen, J., Phaiphun, L., et al. (2008) A Randomized Controlled Trial of Artemether-Lumefantrine versus Artesunate for Uncomplicated Plasmodium falciparum Treatment in Pregnancy. PLOS Medicine, 5, e253.